Cancer has always been and will always be one of the deadliest diseases out there. With it affecting a large portion of the world, it is known for being hard or impossible to treat. Researchers are in a race trying to find solutions and treatments to control, cure and prevent cancer.
Only recently a study has showed that precision cancer drugs called PARP might actually be used to cure cancer. This is due to the strong effect it has on the immune system of humans, boosting its abilities. The use of PARP previously was limited, as this characteristic was not yet known or observed. The study suggest that it should be used with immunotherapies to boost their effect.
The study conducted at The Institute of Cancer Research, London, and the Institut Gustave Roussy, France, showed that PARP can destroy cancer cells and still evade the immune system. Clinical trials are already in progress for further results and data.
The effective drug for ovarian and breast cancer has been tested with lung cancer. The results showed that the PARP might treat lungs cancer through their DNA repair to damaged DNA in the lungs.
Professor Chris Lord, leader of the study said, ”The findings of this study substantially change our understanding of how PARP inhibitors work. We now know that they not only kill tumours by damaging their DNA, but also by attracting immune cells to attack them – acting as a sort of double-pronged attack.”